
 |
 |
 |
Dr. Tim Hunt
(Sir Richard Timothy Hunt)
Principal Scientist
Cancer Research UK Clare Hall Laboratories |
G. Steven Burrill
CEO
Burrill & Company |
Jeong-Sun SEO
Prof.,
College of Medicine,
Seoul Nat'l Univ. |
|
|
|

Track 1. BioIndustry in UK & Korea
Session 1. Microfluidics System
 |
 |
 |
Andrew J. deMELLO
Co-founder,
Molecular Vision Ltd.
Prof., Chemistry,
Imperial College London |
Jaebum CHOO
Prof.,
Dept. of Applied Chemistry,
Hanyang Univ. |
Jon M. COOPER
Co-founder, MODE DX Ltd. Leader, Bioengineering,
Univ. of Glasgow |
|
|
|
Session 2. High Throughput Analysis for Diagnosis and Drug Discovery
 |
 |
 |
Robin J. LEATHERBARROW
Prof., Chemistry,
Imperial College London |
MoonHee HAN
CEO, Proteotgen, Inc. |
Danny O'HARE
Co-founder, Medermica Ltd. Leader, Bioengineering,
Imperial College London |
|
|
|
Session 3. Stem Cell and Biologics
 |
 |
 |
Yeup YOON
Director,
Mogam Biotechnology
Research Inst. |
Hyung-Min CHUNG
President,
CHABio&Diostech Co., Ltd. |
Athanasios MANTALARIS
Co-founder, MedCell Ltd. Leader, Chemical Engineering, Imperial College London |
|
|
 |
Session 3. Stem Cell and Biologics
 |
 |
 |
Nigel Whittle
R&D Specialist, UKTI R&D Programme, UK Trade & Investment
|
Naomitsu ABE
Senior Manager, Primary Markets, London Stock Exchange - Hong Kong |
Fabian SEYMOUR
Innovation Manager, Cels Group |
|
|
|
 |
Sangdeok HAN
Director & Chief Secretary, Chairman’s Secretary Office, Sewon Cellontech Co., Ltd.
|
|
Track 2. Issues to Address in Life Science BD & Funding
Session 1. Update on Changing Trends in Venture Investments
 |
 |
 |
Mike MURRAY
Managing Director,
Sosei R&D Ltd. |
Hui-Hsing MA
General Partner, Life Sciences, TVM Capital |
Jeong Hyun KIM
Executive Director, E&Networks Venture Investment |
 |
 |
|
Session 2. Critical Issues for Successful IR of Life Science Venture Companies
 |
 |
 |
Nelson TENG
Managing Partner,
Charter Life Sciences |
Adam BRISTOL
Portfolio Manager, Biotechnology Value Fund, LP |
Stephen LEE
Principal,
Bio-Strategies Consulting |
|
|
|
Track 3. Technology Transfer and Licensing
:Technology Innovation and Commercialization for Life Science
Session 1. Building and Enforcing IP Value in Korea
 |
 |
 |
Sunhee (Sunny) LEE
Partner,
Sughrue Mion, PLLC. |
Kyujeong AHN
Patent Examiner,
Biotechnology Examination Div.,
Industrial Property Office |
Richard CHIN CEO, Inst. for OneWorld Health |
|
|
|
Session 2. The Journey from Discovery to the Market in the Life Sciences
 |
 |
 |
Steven M. FERGUSON
Deputy Director,
Licensing & Entrepreneurship,
Office of Tech. Transfer,
Nat'l Institutes of Health (U.S.) |
Ann M. HAMMERSLA
Chief, Office of Tech. Transfer, Nat'l Institutes of Health (U.S.) |
Sung-Joo E. LEE
Deputy General Manager, R&D Strategic Planning, LG Life Sciences, Ltd. |
|
|
|
Session 3. Supporting Activities for Technology Commercialization
 |
 |
 |
Ann M. HAMMERSLA
Chief, Office of Tech. Transfer, Nat'l Institutes of Health (U.S.) |
Steven M. FERGUSON
Deputy Director,
Licensing & Entrepreneurship,
Office of Tech. Transfer,
Nat'l Institutes of Health (U.S.) |
Dianne GLENN
DI, Corelli Consulting
|
 |
|
|
 |
|
|
Benjamin P. CHEN
Managing Director,
Burrill & Company |
|
|
 |
|
|
Session 4. View of Negotiation for Investment & Cooperation
 |
 |
 |
Nancy T. CHANG
Chairman & Sr. Managing Director, Asia, OrbiMed Advisors
|
Stephen M. SAMMUT
Venture Partner, Burrill & Company / Senior Fellow, Wharton School
|
Benjamin P. CHEN
Managing Director,
Burrill & Company
|
|
|
|
Track 4. Traditional Medicine : R&D on Traditional Medicine
Session 1. Recent Trends of R&D for Traditional Medicine in East-Asia
 |
 |
 |
Hong Xin CAO
President,
China Academy of Chinese Medical Sci. |
Toshihiko HANAWA
President,
Kitasato Univ. Oriental Medicine Research Center |
Yun-Lian LIN
Research Fellow & Deputy Director, Medicinal Chemistry, Nat'l Research Inst. of Chinese Medicine
|
|
|
|
 |
|
|
Ki-ok KIM
President,
Korea Inst. of Oriental Medicine |
|
|
|
|
|
Session 2. Recent Policy Trends of Traditional Medicine in East-Asia
 |
 |
 |
Zhiren XU
Director-general,
Dept. of Medical Affairs Management,
State Administration of Traditional Chinese Medicine |
I-hsin LIN
Chairperson,
Dept. of Health,
Executive Yuan,
Committee on Chinese Medicine and Pharmacy |
Yong-ho KIM
Director, Bureau of TKM,
Ministry for Health, Welfare
and Family Affairs |
|
|
|
Track 5. Korea-Scotland Joint Symposium
Welcome Speech
 |
|
|
Tony BAKER
Director,
Life Sciences, Scottish Development Int'l
|
|
|
 |
|
|
Session 1. Diabetes and Pharmacogenomics
 |
 |
 |
Calum SUTHERLAND
Prof.,
Dundee Diabetes Research Center, Ninewells Medical School of Dundee |
Jae-Gook SHIN
Prof.,
Dept. of Pharmacology and Clinical Pharmacology, Pharmacogenomics Research Center, College of Medicine, Inje Univ. |
Colin NA PALMER
Chair of Pharmacogenomics, Biomedical Research Inst., Univ. of Dundee |
|
|
|
Session 2. Diabetes and Therapeutics
 |
 |
 |
Stephen M. HAMMOND
Prof.,
Yoshitomi Inst. in Neurosciences, Univ. of Glasgow |
Thomas Jung-Woog SHIN
Prof.,
Dept. of Biomedical Engineering, Inje Univ. |
Steve GIBSON
Director,
Vitrology Ltd. |
 |
|
|
Track 6. Recent Advances of Stem Cell Differentiation
Session 1. Cell Differentiation from Human ES Cells
 |
 |
 |
Hyung-Min CHUNG
President,
CHABio&Diostech Co., Ltd. |
Jong-Hoon KIM
Associate Prof.,
Lab. of Stem Cell Biology,
College of Life Sciences & Biotechnology,
Korea Univ. |
Shi-Jiang LU
Senior Director,
Stem Cell & Regenerative Medicine Int'l |
|
|
|
Session 2. Derivation of Tissue Specific Stem Cell
 |
 |
 |
Jeong Mook LIM
Prof.,
Dept. of Agricultural Biotech.,
Seoul Nat'l Univ
|
Kinarm KO
Research Associate, Dept. of Cell and Developmental Biology, Max Planck Inst. for Molecular Biomedicine
|
Dong Wook HAN
Post Doc., Dept. of Cell and Developmental Biology, Max Planck Inst. for Molecular Biomedicine
|
|
|
|
Track 7. APEC Harmonization Center Workshop
Session 1. To be announced
Session 2. To be announced
Session 3. To be announced
Track 8. Regenerative Medicine
Session 1. Recent Advances of Stem Cell
 |
 |
 |
Yong-Mahn HAN
Prof.,
Dept. of Biological Sciences,
KAIST |
Youngsook SON
Prof., College of Life Sci.,
Kyung Hee Univ. |
Dong-Wook KIM
Prof.,
Stem Cell Research Center,
Yonsei Univ. |
|
|
|
Session 2. Global Development Trends for Cell Therapy
 |
 |
 |
Wonil OH
Director,
Biomedical Research Inst.,
MEDIPOST, Co., Ltd.
|
Yukio HASEGAWA
President & CEO,
CellSeed Co. |
Mihyung KIM
Managing Director,
Anterogen Co. Ltd.
|
|
|
|
Session 3. Recent Advances of Tissue Engineering
 |
 |
 |
Rui REIS
Prof., 3B' Research Inst.,
Univ. of Minho
|
Byung Hyun MIN
Prof., Orthpeadic Surg.,
Ajou Univ. Medical School |
Minoru UEDA
Prof., Dept. of Oral and Maxillofacial Surgery,
School of Medicine,
Nagoya Univ.
|
|
|
|
Track 9. Pharmaceutical Strategy for Incrementally Modified Drug
Session 1. Efficient Drug Delivery for IMD Strategies
 |
 |
 |
Hoo-Kyun CHOI
Prof., College of Pharmacy , Chosun Univ. |
Soo-Jeong LIM
Associate Prof.,
Dept. of Bioscience & Bioengineering,
Sejong Univ. |
Sung-Joo HWANG
Prof., College of Pharmacy, Chungnam Nat'l Univ. |
|
|
|
Session 2. IMD Strategies for Biopharmaceuticals
 |
 |
 |
Tae Gwan PARK
Prof.,
Dept. of Biological Sciences,
KAIST |
Yong-Hee KIM
Associate Prof.,
Dept. of Bioengineering,
Hanyang Univ. |
Moon Suk KIM
Assistant Prof.,
Dept. of Molecular Sci. and Tech.,
Ajou Univ. |
|
|
|
Session 3. Advanced IMD Technologies for Next Generations
 |
 |
 |
Jonghwi LEE
Associate Prof.,
Dept. of Chemical Engineering and Materials Sci.,
Chung-Ang Univ. |
Myung-Ok PARK
CEO, BiopolyMed Inc. |
Seongbong JO
Assistant Prof.,
Pharmacy/Pharmaceutics,
The Univ. of Mississippi |
|
|
|
Track 10. Strategy for Overseas Generic Marketing
Session 1. Innovative and Specific Strategy for the Participation of Korean Generic
Industry for the World-market
 |
 |
 |
Ram MURTY
President & CEO,
Murty Pharmaceuticals, Inc. |
Beom-Jin LEE
Prof., College of Pharmacy , KangWon Nat'l Univ. |
Gwan Sun LEE
Managing Research Director & Head of Hanmi Research Center, Hanmi Pharm. Co., Ltd. |
|
|
|
Session 2. Market Analysis and Measures for Korean Generic Drug Export to the World
Market
 |
 |
 |
Soo Youn CHUNG
Chief, Bioequivalence Div., Korea Food & Drug Administration |
Chung Keel LEE
Special Advisor to the Commissioner,
Korea Food & Drug Administration |
Sang-Joon LEE
Executive Vice President,
Business Div.,
Kolon Life Science, Inc. |
|
|
|
Session 3. Generic Drug Patent Strategy for International Marketing
 |
 |
 |
Joo Mee KIM
Partner,
Rothwell, Figg, Ernst &
Manbeck, P.C. |
Kyung Ae YOON
Director,
Korea Inst. of Patent Information |
So Young AHN
Patent Attorney, Dr. Ahn Int'l Patent Law Office |
|
 |
|
 |
Eun-Ju RYU
Director, Emerging Market Business Unit, Pfizer Inc.
New York |
|
Track 11. Therapeutic Antibody
Session 1. Therapeutic Antibody 1
 |
 |
 |
Zhenping ZHU
Vice President & Global Head, Protein Sciences & Design, Novartis Biologics |
Shin-Jae CHANG
Vice President, Celltrion, Inc. |
Kum-Joo SHIN
Director, Research, Abxign |
|
|
|
Session 2. Therapeutic Antibody 2
 |
 |
 |
Herren WU
Vice President & Global Head of Tech. and Lead Generation, Antibody Discovery & Protein Engineering, MedImmune |
Kyoung E. KIM
General Manager, KIM, General Manager, BIO Businee Team, Hanwha Group/Dream Pharma |
June-Young PARK
Director,
Business Development,
Isu Abxis Co., Ltd. |
|
|
|
Session 3. Therapeutic Antibody 3
 |
 |
 |
Henrik IHRE
Program Manager Antibodies, Life Sciences Div., GE Healthcare |
Peter PARK
Senior Director, Discovery Research, ImmunoGen, Inc. |
Se-Ho KIM
Research Director,
Green Cross Corp. |
|
|
|
 |
Dae Hee KIM
Principal Investigator,
Scripps Korea |
|
Track 12. u-Health
Session 1. Policies and Vision
 |
 |
 |
Young Hae KIM
Director,
u-Project Team / u-Service Div.,
Nat'l Information Society Agency |
Duk Won KIM
Team Manager, Marketing Team, Evercare |
Kenich SASAKI
Senior Consultant,
Nomura Research Inst. |
|
|
|
Session 2. Technology and Standardization
 |
 |
 |
Suk Wha KIM
Prof.,
Dept. of Plastic Surgery,
College of Medicine,
Seoul Nat'l Univ. |
Woo Kyeong SEONG
Director,
Medical IT Comvergence Research Center,
Korea Electronics Tech. |
Kyung Soo JIN
Prof.,
Dept. of Medical Electronics,
Chungbuk Provincial College |
|
|
|
Session 3. Business Models
 |
 |
 |
Kun-Ho YOON
Prof.,
Dept. of Endocrinology & Metabolism,
The Catholic Univ. of Korea |
Young Woo PAE
Manager,
IBM Ubiquitous Computing Lab,
IBM Korea |
Tae Il KWON
Director,
Healthcare Business Div.,
Uracle |
|
|
|
Track 13. Recent Trends on Biochip Technology
Session 1. Recent Progress in Protein and DNA Chips
 |
 |
 |
Shao Q YAO
Associate Prof.,
Dept. of Chemistry,
Nat'l Univ. of Singapore |
Hak-Sung KIM
Prof.,
Dept. of Biological Sciences,
KAIST |
Suk Woo NAM,
Associate Prof.,
Dept. of Pathology,
College of Medicine,
The Catholic Univ. |
|
|
|
Session 2. Nano and Biomedical Sensor Technologies
 |
 |
 |
Hagen THIELECKE
Head,
Dept. of Biohybrid Systems,
Fraunhofer IBMT |
Jae-Chul PYUN
Assistant Prof.,
Dept. of Materials Sci. and Engineering,
Yonsei Univ. |
Sangmin JEON
Associate Prof.,
Dept. of Chemical Engineering,
Pohang Univ. of Sci. and Tech. |
|
|
|
Session 3. Microfluidic Chips for Cells
 |
 |
 |
Ali KHADEMHOSSEINI
Prof., Harvard-MIT HST,
Harvard Medical School |
Noo Li JEON
Associate Prof.,
School of Mechanical and Aerospace Engineering,
Seoul Nat'l Univ. |
Je-Kyun PARK
Prof.,
Dept. of Bio and Brain Engineering,
KAIST |
|
|
|
Track 14. Clinical Drug Development
Session 1. Early Phase Product Development:
Helping Korean Companies to Access Western Markets
 |
 |
 |
Maree SMITH
CEO, TetraQ |
Suzanne ELLIOTT
Operations Manager,
Q-Pharm Pty Ltd. |
Dianne Jackson-Matthews
Deputy Group Director,
ERA Consulting |
|
|
|
Session 2. New Tools for Early Phase Clinical Drug Development
 |
 |
 |
Kyung-Sang YU
Prof.,
College of Medicine and Hospital,
Seoul Nat'l Univ. |
Kyungsoo PARK
Associate Prof.,
Pharmacology, College of Medicine,
Yonsei Univ. |
Hyeong-Seok LIM
Assistant Prof.,
Dept. of Clinical Pharmacology and Therapeutics,
Asan Medical Center,
Univ. of Ulsan |
|
|
|
Session 3. Strategies for Successful Development of Biopharmaceuticals
 |
 |
 |
Seok H. LEE
Senior Advisor, Celltrion, Inc. |
Woo Suk KOH
Senior Researcher,
Korea Inst. of Toxicology, KRICT |
Chulho PARK
Head, Process Sciences,
Pre-Clinical Development,
aTyr Pharma
|
|
|
|
Track 15. Bioactive Medical Implants
Session 1. Biocompatible Implants in Medicine
 |
 |
 |
Dave GRAINGER
Prof. & Chair,
Dept. of Pharmaceutics,
Univ. of Utah |
Hun Kuk PARK
Prof.,
Dept. of Biomedical Engineering,
School of Medicine,
Kyung Hee Univ. |
Ki Dong PARK
Prof.,
Dept. of Molecular Sci.
and Tech.,
Ajou Univ. |
|
|
|
Session 2. Cardiovascular Implants
 |
 |
 |
Dehua CHANG
Assistant Prof.,
Inst. of Advanced Biomedical Engineering and Sci.,
Tokyo Women's Mediclal Univ. |
Dong Hoon CHOI
Prof.,
Dept. of Cardic Internal Medicine,
School of Medicine,
Yonsei Univ. |
Yang Ha CHO
Director,
Medical Device Standardization,
Medical Device Evaluation,
Korea Food & Drug Administration |
|
|
|
Session 3. Skeletal (Spinal, Orthopedic, and Dental) Implants
 |
 |
 |
Young KU
Prof.,
Dept. of Periodontology,
School of Dentistry,
Seoul Nat'l Univ. |
Yong Sik KIM
Prof., Dept. of Neurological Surgery, ASAN Medical Center, College of Medicine, Univ. of Ulsan |
Sung Jae LEE
Prof.,
Dept. of Biomedical
Engineering,
Inje Univ. |
|
|
 |
Track 16. Regulatory and GMP Compliance
Session 1. Updated Regulatory Issues for Biologicals
 |
 |
 |
Chung Keel LEE
Special Advisor to the Commissioner,
Korea Food & Drug Administration |
Younjoo PARK
Director, Biologics Research Div., Nat’l Inst. of Food & Drug Safety Evaluation, Korea Food & Drug Administration |
Seunghwa HONG
Director,
Nat'l Inst. for Food & Drug
Safety Evaluation |
|
|
|
Session 2. GMP Facility Design and Operation
 |
 |
 |
Luke DeMAYO
Senior Technical Manager, Process Tech., Middough Inc. |
Thomas PAUST
Director,
Satorius Stedim Biotech |
Yeong Ok BAIK
Director,
Dept. of Biologics Manufacturing,
KBCC, KITECH |
|
|
|
Session 3. QC/QA
 |
 |
 |
K.C. CHENG
Director,
Analytical and Formulation Development,
Medarex, Inc. |
Do Yeon LEE
Manager, QA Team 1,
Center for Quality Assurance,
Pharmaceutical BU.,
CJCheilJdang Corp. |
MinYoung SOH
Senior Vice President,
Celltrion, Inc. |
|
|
|
Track 17. Vaccine
Session 1. Vaccine Industry in Asia: Challenge and Opportunity
 |
 |
 |
John CLEMENS
Secretary General,
Int'l Vaccine Inst. |
Giang GAO
CTO, Sinovac |
Thu Van NGUYEN
Director General, Vaccine,
The Company for Vaccine and Biological No.1 |
|
 |
|
 |
|
|
Byung Geon RHEE
Executive Vice President, Green Cross Corp. |
|
|
|
|
|
Session 2. Prospective Vaccine R&D
 |
 |
 |
Dennis J. KOPECKO
Lab Chief, Div. of Bacterial, Parasitic and Allergenic Products, FDA-CBER |
Baik Lin SEONG
Prof., Yonsei Univ. |
Youngchul SUNG
Prof., Dept. of Life Sci., Pohang Univ. of Sci. and Tech. |
|
|
|
 |
|
|
Joon Haeng RHEE
Prof., Dept. of Microbiology,
Medical School,
Chonnam Nat'l Univ. |
|
|
|
|
|
Track 18. Next-generation Sequencing
: Next-generation Sequencing Towards Personalized Medicine
Session 1. Application of Next-generation Sequencing to Personal Genomics
 |
 |
 |
Charles LEE
Prof., Harvard Cancer Center, Harvard Univ. |
Ituro INOUE
Prof., School of Medicine,
Tokai Univ. |
Sun KIM
Prof., School of Informatics, Indiana Univ. |
 |
|
|
Session 2. The Present of Next-generation Genome Sequencing in Korea
 |
 |
 |
Yoon Shin CHO
Principal Research Scientist, Center for Genome Sci.,
Korean Nat'l Inst. of Health, KCDC |
Kap-Seok YANG
CTO, Macrogen Inc. |
Yong Sung KIM
Principle Investigator, Medical Genomic Research Center, Korean Research Inst. of Biosci. and Biotech.
|
|
|
|
Session 3. Introduction of Next-generation Sequencing Technology to Personal Medicine
 |
 |
 |
Yafei LIU
Head,
Sequencing Business,
Illumina |
Chinnappa KODIRA
Director, Genomics,
454 Life Sciences Corp. |
Mike PAYNE
Regional Lead Applications Support, Applied Biosystems
|
|
|
|
Track 19. Botanical New Drug Discovery and Development
Session 1. Development of Botanical New Drug
 |
 |
 |
Hocheol KIM
Prof., Dept. of Herbal Pharmacology, College of Oriental Medicine, Kyung Hee Univ. / CEO, NeuMed Inc. |
Bongyong LEE
R&D General Manager, Life Sci. R&D Center, SK Chemicals |
Hyeong-Kyu LEE
Vice President & General Director,
Bio-therapeutics Research Inst.,
Korea Research Inst. of Bioscience and Biotechnology |
|
|
|
Session 2. Regulation of Botanical Products
 |
 |
 |
Sang Hyun SUNG
Assistant Prof.,
College of Pharmacy,
Seoul Nat'l Univ. /
CEO, Elcom Science Co., Ltd. |
Shin Jung KANG
Director,
Medicinal Herbal Products Div.,
Korea Food & Drug Administration |
Hye Young LEE
Senior Officer, Div. of Functional Food, Dept. of Nutrition & Functional Food, Korea Food & Drug Administration |
|
|
|
Session 3. Global Market of Botanical Products
 |
 |
 |
Hee Min RHEE
Principal Investigator,
Int'l Scientific Standard, Inc. |
Ming-Wei WANG
Director,
The Nat'l Center for Drug Screening |
Hirobumi OHAMA
Chairman of the Board,
The Japanese Inst. for Health Food Standards |
|
|
|